RMTI

$1.06

Pre-MarketAs of Mar 17, 8:00 PM UTC

Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.06
Potential Upside
5%
Whystock Fair Value$1.11
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid co...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$41.77M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.76
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-16.68%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
3.34

Recent News

Zacks
Feb 16, 2026

Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors

Rockwell Medical (RMTI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Feb 13, 2026

Are Investors Undervaluing Rockwell Medical (RMTI) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Jan 28, 2026

Rockwell Medical (RMTI) Upgraded to Buy: Here's What You Should Know

Rockwell Medical (RMTI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Jan 28, 2026

Is Rockwell Medical (RMTI) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Jan 28, 2026

Despite Fast-paced Momentum, Rockwell Medical (RMTI) Is Still a Bargain Stock

Rockwell Medical (RMTI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.